作者:Pasquale Linciano、Carolina B. Moraes、Laura M. Alcantara、Caio H. Franco、Bruno Pascoalino、Lucio H. Freitas-Junior、Sara Macedo、Nuno Santarem、Anabela Cordeiro-da-Silva、Sheraz Gul、Gesa Witt、Maria Kuzikov、Bernhard Ellinger、Stefania Ferrari、Rosaria Luciani、Antonio Quotadamo、Luca Costantino、Maria Paola Costi
DOI:10.1016/j.ejmech.2018.01.043
日期:2018.2
interesting activity against the same organisms. The compounds were particularly effective against T. brucei and T. cruzi. Among the 28 synthesized compounds, the best one was (E)-2-(4-((3.4-dichlorobenzyl)oxy)benzylidene) hydrazinecarbothioamide (A14) yielding a comparable anti-parasitic activity against the three parasitic species (TbEC50 = 2.31 μM, LiEC50 = 6.14 μM, TcEC50 = 1.31 μM) and a Selectivity Index
基于显示出抗锥虫病活性的噻二唑衍生物库,我们已经考虑了噻二唑的开放形式和反应中间体硫代半脲类化合物,作为针对布鲁氏锥虫(Tb),婴儿利什曼原虫(Li)和克氏锥虫(Tc)。相似的化合物已经显示出对相同生物的有趣活性。该化合物对T. brucei和T. cruzi特别有效。在这28种合成的化合物中,最好的一种是(E)-2-(4-((3.4-二氯苄基)氧基)亚苄基)肼基甲硫代酰胺(A14)针对三种寄生物(Tb EC 50 = 2.31μM,Li EC 50 = 6.14μM,Tc EC 50 = 1.31μM )产生可比的抗寄生虫活性,并且相对于人类巨噬细胞的选择性指数高于10,因此显示泛抗锥虫病活动。(E)-2-(((3'.4'-二甲氧基-[1.1'-联苯] -3-基]甲基)甲基)肼基甲硫代酰胺(A12)和(E)-2-(4-((3.4-二氯苄基)氧基)苯亚甲基)肼硫代甲酰胺(A14)在组